A Canadian company focused on psychedelic-inspired mental health treatment is collaborating with the University of Calgary in a clinical trial for a candidate that treats cancer-related distress.
The university’s Hotchkiss Brain Institute and Enveric Biosciences will team up to establish a trial of EVM-101. About 50%...
